Arexvy could help NHS deal with virus that causes about 8,000 deaths among older people in UK each year
The UK’s medicines regulator has approved the first vaccine against respiratory syncytial virus (RSV) in older adults.
The virus typically causes cold-like symptoms, but is a leading cause of pneumonia in infants and elderly people, with infections in older adults accounting for about 8,000 deaths, 14,000 hospitalisations and 175,000 GP appointments in the UK each year – more than influenza during a typical winter season.
About Author
More Stories
Esports are booming in Africa – but can its infrastructure keep pace?
Experts warn of mental health risks after rise in magic mushroom use
Canadian researchers trial nature trick to boost mood in winter